The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/23813
StudyName: Eligibility Colorectal Cancer NCT00478634
Date of export from the portal: 02.07.2020
Date of Upload / last change: 14.07.2017
License: Creative Commons BY 4.0

----

Description: 
A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00478634
